- Investing Ideas
- /
- Global Top Stock Picks from Analysts
Global Top Stock Picks from Analysts
UPDATED Apr 25, 2024
Potentially undervalued companies with a strong past performance and robust balance sheet.
1,076 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$399.04 | -1.3% | 30.9% | US$3.0t | US$471.24 | PE35.9x | E12.6% | 0.8% | Software | ||
GOOGL | US$156.00 | -0.006% | 45.0% | US$2.0t | US$166.83 | PE26.3x | E11.9% | n/a | Media | ||
AMZN | US$173.67 | -3.1% | 58.1% | US$1.8t | US$210.59 | PE59.4x | E21.6% | n/a | Retail | ||
META | US$441.38 | -12.0% | 85.0% | US$1.1t | US$524.32 | PE24.5x | E12.3% | 0.5% | Media | ||
2330 | NT$782.00 | 4.3% | 55.8% | NT$20.3t | NT$912.98 | PE23.7x | E16.1% | 1.8% | Semiconductors | ||
NOVO B | kr.886.60 | 2.4% | 57.7% | kr.3.9t | kr.904.20 | PE47.3x | E14.7% | 1.1% | Pharmaceuticals & Biotech | ||
CRM | US$273.14 | 0.4% | 39.4% | US$264.9b | US$336.10 | PE64.1x | E18.7% | 0.6% | Software | ||
ADBE | US$473.44 | 0.05% | 27.5% | US$212.1b | US$617.38 | PE44.2x | E17.1% | n/a | Software | ||
NOVN | CHF90.00 | 5.2% | -1.2% | CHF183.6b | CHF98.99 | PE22.1x | E9.9% | 3.7% | Pharmaceuticals & Biotech | ||
ROG | CHF218.80 | -1.5% | -22.0% | CHF176.4b | CHF279.39 | PE15.2x | E8.6% | 4.4% | Pharmaceuticals & Biotech | ||
PDD | US$125.79 | 10.6% | 90.2% | US$174.7b | US$179.67 | PE21.1x | E23.0% | n/a | Retail | ||
AXP | US$237.10 | 9.0% | 49.6% | US$170.5b | US$223.21 | PE19.2x | E7.5% | 1.2% | Diversified Financials | ||
AIR | €158.52 | -0.9% | 24.7% | €125.4b | €177.35 | PE32x | E18.4% | 1.1% | Capital Goods | ||
VRTX | US$397.70 | 1.1% | 17.2% | US$102.8b | US$460.34 | PE28.4x | E11.5% | n/a | Pharmaceuticals & Biotech | ||
SAF | €207.50 | 0.8% | 47.2% | €85.8b | €206.26 | PE24.9x | E5.8% | 1.1% | Capital Goods | ||
CSL | AU$273.30 | 1.4% | -9.1% | AU$132.1b | AU$306.71 | PE34.9x | E14.7% | 1.3% | Pharmaceuticals & Biotech | ||
1299 | HK$54.00 | 14.4% | -36.4% | HK$604.6b | HK$94.88 | PE20.5x | E18.2% | 3.0% | Insurance | ||
CRWD | US$298.02 | 1.3% | 136.4% | US$72.1b | US$390.62 | PE806.9x | E34.6% | n/a | Software | ||
SLB | US$49.44 | -2.9% | 3.1% | US$70.7b | US$67.11 | PE16.3x | E13.1% | 2.2% | Energy | ||
NTES | US$94.12 | 1.8% | 6.3% | US$60.7b | US$132.85 | PE14.9x | E7.9% | 2.7% | Media | ||
2454 | NT$1,005.00 | 1.2% | 51.1% | NT$1.6t | NT$1,199.29 | PE20.8x | E14.0% | 6.0% | Semiconductors | ||
300760 | CN¥288.80 | 6.4% | -7.4% | CN¥349.3b | CN¥396.59 | PE30.8x | E15.0% | 3.0% | Healthcare | ||
BBRI | Rp4,830.00 | -8.4% | -5.3% | Rp776.6t | Rp6,591.96 | PB2.5x | E11.9% | 6.6% | Banks | ||
BMRI | Rp6,750.00 | 0.4% | 30.4% | Rp648.7t | Rp7,544.68 | PB2.4x | E9.4% | 5.2% | Banks |